CAD 0.1
(-9.09%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -220.47 Thousand CAD | -4.54% |
2022 | -210.9 Thousand CAD | -236.41% |
2021 | -62.69 Thousand CAD | -204.04% |
2020 | -20.62 Thousand CAD | 11.77% |
2019 | -23.37 Thousand CAD | 19.05% |
2018 | -28.87 Thousand CAD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | -24.47 Thousand CAD | 60.54% |
2024 Q1 | -62.01 Thousand CAD | 1.42% |
2024 Q3 | -52.48 Thousand CAD | -114.47% |
2023 FY | -220.48 Thousand CAD | -4.54% |
2023 Q4 | -62.9 Thousand CAD | 17.7% |
2023 Q2 | -24.3 Thousand CAD | 57.24% |
2023 Q1 | -56.83 Thousand CAD | 24.28% |
2023 Q3 | -76.43 Thousand CAD | -214.5% |
2022 Q4 | -75.05 Thousand CAD | -163.21% |
2022 Q3 | -28.51 Thousand CAD | 51.89% |
2022 Q2 | -59.27 Thousand CAD | -4.81% |
2022 Q1 | -56.55 Thousand CAD | -1583.18% |
2022 FY | -210.9 Thousand CAD | -236.41% |
2021 Q2 | -11.18 Thousand CAD | 0.0% |
2021 FY | -62.69 Thousand CAD | -204.04% |
2021 Q4 | -3360.00 CAD | 65.82% |
2021 Q3 | -9830.00 CAD | 12.08% |
2020 FY | -20.62 Thousand CAD | 11.77% |
2019 FY | -23.37 Thousand CAD | 19.05% |
2018 FY | -28.87 Thousand CAD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Biosenta Inc. | -1.5 Million CAD | 85.398% |